Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins
Viruses · 2024
DOI: 10.3390/v16091492 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2024. Verfasst von Syamala Rani Thimmiraju und 6 weiteren Autor:innen. Beteiligte Einrichtung: Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, SARS-CoV-2, HIV-1, Transduction, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Over the past three years, new SARS-CoV-2 variants have continuously emerged, evolving to a point where an immune response against the original vaccine no longer provided optimal protection against these new strains. During this time, high-throughput neutralization assays based on pseudoviruses have become a valuable tool for assessing the efficacy of new vaccines, screening updated vaccine candidates against emerging variants, and testing the efficacy of new therapeutics such as monoclonal antibodies. Lentiviral vectors derived from HIV-1 are popular for developing pseudo and chimeric viruses due to their ease of use, stability, and long-term transgene expression. However, the HIV-based platform has lower transduction rates for pseudotyping coronavirus spike proteins than other pseudovirus platforms, necessitating more optimized methods. As the SARS-CoV-2 virus evolved, we produced over 18 variants of the spike protein for pseudotyping with an HIV-based vector, optimizing experimental parameters for their production and transduction. In this article, we present key parameters that were assessed to improve such technology, including (a) the timing and method of collection of pseudovirus supernatant; (b) the timing of host cell transduction; (c) cell culture media replenishment after pseudovirus adsorption; and (d) the centrifugation (spinoculation) parameters of the host cell+ pseudovirus mix, towards improved transduction. Additionally, we found that, for some pseudoviruses, the addition of a cationic polymer (polybrene) to the culture medium improved the transduction process. These findings were applicable across variant spike pseudoviruses that include not only SARS-CoV-2 variants, but also SARS, MERS, Alpha Coronavirus (NL-63), and bat-like coronaviruses. In summary, we present improvements in transduction efficiency, which can broaden the dynamic range of the pseudovirus titration and neutralization assays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Texas Children's Hospital Center for Vaccine Development, Houston, TX 77030, USA.
- Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
- Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX 77030, USA.
ORCID-Profile: Jason T Kimata, Ulrich Strych, Maria Elena Bottazzi, Jeroen Pollet
Förderung
- NIAID NIH HHS
- NCI NIH HHS
- NIH HHS
- CPRIT
- Texas Children’s Hospital Center for Vaccine Development Intramural Funds, USA
- Cytometry and Cell Sorting Core at Baylor College of Medicine
- NIH
Zitieren
APA
Thimmiraju, S. R., Villar, M. J., Kimata, J. T., Strych, U., Bottazzi, M. E., Hotez, P. J., & Pollet, J. (2024). Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. https://doi.org/10.3390/v16091492
Vancouver
Thimmiraju SR, Villar MJ, Kimata JT, Strych U, Bottazzi ME, Hotez PJ, et al. Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins. Viruses. 2024. doi:10.3390/v16091492
BibTeX
@article{Thimmiraju2024,
author = {Thimmiraju, Syamala Rani and Villar, Maria Jose and Kimata, Jason T and Strych, Ulrich and Bottazzi, Maria Elena and Hotez, Peter J and Pollet, Jeroen},
title = {Optimization of Cellular Transduction by the HIV-Based Pseudovirus Platform with Pan-Coronavirus Spike Proteins},
journal = {Viruses},
year = {2024},
doi = {10.3390/v16091492}
}
EUVIMED